Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Interferon Beta-1α ring prophylaxis to reduce household transmission of SARS-CoV-2

José A. Castro-Rodriguez, Eleanor N. Fish, Tobi Kollmann, Carolina Iturriaga, Yuliya Karpievitch, View ORCID ProfileCasey Shannon, Virginia Chen, View ORCID ProfileRobert Balshaw, Samuel Montgomery, Joseph Ho, Rym Ben Othman, Radhouana Aniba, Francisca Gidi-Yunge, Lucy Hartnell, Guillermo Pérez-Mateluna, Marcela Urzúa, View ORCID ProfileScott Tebbutt, Diego García-Huidobro, Cecilia Perret, Arturo Borzutzky, Stephen M. Stick
doi: https://doi.org/10.1101/2022.06.13.22276369
José A. Castro-Rodriguez
1Pontifical Catholic University of Chile
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor N. Fish
2University of Toronto
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobi Kollmann
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Iturriaga
1Pontifical Catholic University of Chile
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuliya Karpievitch
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casey Shannon
4Prevention of Organ Failure (PROOF) Centre of Excellence
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Casey Shannon
Virginia Chen
4Prevention of Organ Failure (PROOF) Centre of Excellence
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Balshaw
5Centre for Healthcare Innovation, University of Manitoba
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Balshaw
Samuel Montgomery
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Ho
3Telethon Kids Institute
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rym Ben Othman
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Radhouana Aniba
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisca Gidi-Yunge
1Pontifical Catholic University of Chile
DDS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy Hartnell
3Telethon Kids Institute
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Pérez-Mateluna
1Pontifical Catholic University of Chile
Biotech
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcela Urzúa
1Pontifical Catholic University of Chile
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Tebbutt
4Prevention of Organ Failure (PROOF) Centre of Excellence
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott Tebbutt
Diego García-Huidobro
1Pontifical Catholic University of Chile
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Perret
1Pontifical Catholic University of Chile
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arturo Borzutzky
1Pontifical Catholic University of Chile
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Stick
3Telethon Kids Institute
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: stephen.stick@health.wa.gov.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Evidence suggests that early, robust type 1 interferon responses to SARS-CoV-2 are critical determinants for COVID-19 disease outcomes, accelerating viral clearance and limiting viral shedding. Accordingly, we undertook a ring prophylaxis study to determine whether pegylated IFNß-1α could reduce SARS-CoV-2 household transmission.

Methods A household cluster randomized controlled study of IFNß-1α administered to non-hospitalized, symptomatic COVID-19 index cases and treatment-eligible household contacts aged 18-70 years compared to standard care, was conducted. Following randomization participants received IFNß-1α on days 1, 6, and 11 or standard care. Viral shedding was determined by sequential salivary polymerase chain reaction measurements until day 29 in both study arms. A post-hoc ‘at risk population’ was defined as households where the index case was positive at the start of the study and there was at least one treatment eligible contact in a household who tested negative for SARS-CoV-2. Frequentist and Bayesian analyses were undertaken to determine the effects of treatment on (i) reducing viral shedding in index cases and (ii) reducing viral transmission to post-exposure household contacts.

Results In total, 1172 participants in 341 households underwent randomization, with 607 assigned to receive IFNß-1α and 565 to standard care. Based on intention to treat and per protocol analyses, IFNß-1α treatment was ineffective. However, in the ‘at risk’ population, the relative risk of infection was reduced by 23% in treated individuals and that there was a 95% probability that IFNß-1α reduced household transmission.

Conclusion Ring prophylaxis with IFNß-1α reduces the probability of SARS-CoV-2 transmission within a household.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04552379

Clinical Protocols

https://pubmed.ncbi.nlm.nih.gov/34388972/

Funding Statement

This study was funded by: BHP Holdings Pty Ltd Biogen

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Pontifical Catholic University of Chile. Ethics approval granted

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 14, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Interferon Beta-1α ring prophylaxis to reduce household transmission of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interferon Beta-1α ring prophylaxis to reduce household transmission of SARS-CoV-2
José A. Castro-Rodriguez, Eleanor N. Fish, Tobi Kollmann, Carolina Iturriaga, Yuliya Karpievitch, Casey Shannon, Virginia Chen, Robert Balshaw, Samuel Montgomery, Joseph Ho, Rym Ben Othman, Radhouana Aniba, Francisca Gidi-Yunge, Lucy Hartnell, Guillermo Pérez-Mateluna, Marcela Urzúa, Scott Tebbutt, Diego García-Huidobro, Cecilia Perret, Arturo Borzutzky, Stephen M. Stick
medRxiv 2022.06.13.22276369; doi: https://doi.org/10.1101/2022.06.13.22276369
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Interferon Beta-1α ring prophylaxis to reduce household transmission of SARS-CoV-2
José A. Castro-Rodriguez, Eleanor N. Fish, Tobi Kollmann, Carolina Iturriaga, Yuliya Karpievitch, Casey Shannon, Virginia Chen, Robert Balshaw, Samuel Montgomery, Joseph Ho, Rym Ben Othman, Radhouana Aniba, Francisca Gidi-Yunge, Lucy Hartnell, Guillermo Pérez-Mateluna, Marcela Urzúa, Scott Tebbutt, Diego García-Huidobro, Cecilia Perret, Arturo Borzutzky, Stephen M. Stick
medRxiv 2022.06.13.22276369; doi: https://doi.org/10.1101/2022.06.13.22276369

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1757)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (658)
  • Epidemiology (10796)
  • Forensic Medicine (8)
  • Gastroenterology (589)
  • Genetic and Genomic Medicine (2946)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1927)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (291)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12515)
  • Intensive Care and Critical Care Medicine (688)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2798)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1463)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2639)
  • Public and Global Health (5363)
  • Radiology and Imaging (1011)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)